Basic Information
Tern Therapeutics, LLC. was founded in late 2023 and is currently a clinical-stage biopharmaceutical company developing a series of small-molecule candidates to treat serious conditions, including oncology and obesity. The small startup, consisting of Alex Bailey, Christina Ohnsman, and Matthew Rosini, all previously held leadership positions at Regenxbio.
Tern Therapeutics, LLC.
Washington,D.C.,United States of America
unclear
January 01, 2023
patientadvocacy@terntx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios